FREE Account Opening + No Clearing Fees
Loading...
September 25, 2017 - September 27, 2017

Vanta Bioscience IPO Latest News Today

Track all the latest updates and news of Vanta Bioscience IPO.

  1. Fierce Biotechs Quarterly IPO and M&A Roundup: Q224

    July 1, 2024 2:30:00 PM

    Biopharma deal activity plummeted down to Earth in the second quarter, with just a handful of M&A transactions and IPOs studding the mostly dark skies. | The slow quarter follows an exciting first one ...

    Published by : FierceBiotech
  2. CrowdStrike: Five Years Since IPO And Just Getting Started

    June 12, 2024 7:17:00 PM

    CrowdStrike marks the 5-year anniversay of its IPO with significant milestones and momentum and ... [+] being added to the S&P 500. As CrowdStrike marks the fifth anniversary of its IPO ...

    Published by : Forbes
  3. Im�munol�o�gy biotech Alu�mis se�cures $250M in shrunk�en IPO

    June 28, 2024 1:45:00 PM

    Alumis, an immunology drug developer on the cusp of Phase 3, will go public Friday in a smaller IPO than it originally projected. The Bay Area startup sold 13.12 million shares $ALMS at $16 apiece to ...

    Published by : ENDPOINTS NEWS
  4. Arti�va re�files for IPO three years af�ter orig�i�nal plans in a vast�ly dif�fer�ent en�vi�ron�ment

    July 1, 2024 12:04:00 PM

    Artiva Biotherapeutics, a clinical-stage NK cell therapy biotech, is trying again for the public markets, it revealed Friday afternoon in an SEC filing. The San Diego biotech is going for a Nasdaq deb ...

    Published by : ENDPOINTS NEWS
  5. DiamiR Biosciences Files for IPO

    June 29, 2024 1:06:00 AM

    DiamiR Biosciences filed for an initial public offering with the U.S. Securities and Exchange Commission. About Dow Jones Newswires Dow Jones Newswires is a market-moving financial and business ...

    Published by : MarketWatch
  6. Third Rocks Rapport reveals upsized $154M IPO

    June 7, 2024 2:30:00 PM

    Just a few days after Rapport Therapeutics revealed plans for a $122 million IPO, the epilepsy biotech has unveiled an upsized $154 million offering. The Third Rock company�s IPO consists of 8 ...

    Published by : FierceBiotech
  7. Newsmax Considers IPO With Private Placement of Up to $225 Million

    June 10, 2024 10:20:00 PM

    Media network Newsmax plans to publicly list its shares later this year and is looking to raise capital beforehand via a private placement. Boca Raton, Fla.-based Newsmax said Monday in an ...

    Published by : Wall Street Journal
  8. Conservative Cable News Channel Newsmax Wants to IPO. Here�s Why

    June 13, 2024 6:11:00 AM

    And much like Trump�s company (or for that matter stocks like GameStop and AMC Entertainment), Ruddy is hoping that an IPO would engage retail investors, many of whom would express their ...

    Published by : The Hollywood Reporter
  9. Shein IPO Should Be A No Brainer Investment, Yet Caution Reigns

    June 12, 2024 5:15:00 PM

    The founder of Gen Z super brand Shein must be wondering whether the company will ever catch a break over the long-running soap opera that is the fashion retailer�s much vaunted IPO. On the face ...

    Published by : Forbes

Vanta Bioscience IPO Alerts

1. Vanta Bioscience Ltd IPO - Listing  Thursday, October 5, 2017 8:03:46 AM

Vanta Bioscience IPO Listing Date

› Listing Date: Friday, October 6, 2017
› BSE Script Code: 540729
› Listing In: ‘M’ Group of Securities
› ISIN: INE695X01011
› Issue Price: Rs 50 Per Equity Share
› Face Value: Rs 10 Per Equity Share

2. Vanta Bioscience Ltd IPO - Close  Wednesday, September 13, 2017 1:15:34 PM

The issue of Vanta Bioscience Ltd opens on Sep 25, 2017 and closes for subscription on Sep 27, 2017. The equity shares of the company to be list at BSE SME. The price band for the issue has been fixed at Rs 50.

3. Vanta Bioscience Ltd IPO - Open  Wednesday, September 13, 2017 1:15:13 PM

Vanta Bioscience Ltd is entering in the capital market with an IPO of 1,512,000 Equity Shares of Rs 10 aggregating up to Rs 7.56 Cr. The price band for the issue has been fixed at Rs 50.

Vanta Bioscience Ltd (VBL) is a preclinical contract research company whhich offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.

The issue opens on Sep 25, 2017 and closes for subscription on Sep 27, 2017. The equity shares of the company to be list at BSE SME platform.

Vanta Bioscience IPO News & Events FAQs

The Vanta Bioscience IPO is proposed to open on September 25, 2017. The IPO application ends on September 27, 2017.

Retail investors can apply in the retail or non-institutional investor category from September 25, 2017 to September 27, 2017. The Vanta Bioscience IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Vanta Bioscience IPO will open for subscription on September 25, 2017. The public issue will close on September 27, 2017.